Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
N1 is a venture capital firm founded in 2019, with offices located in San Francisco and Prague. The firm focuses on supporting early-stage founders in building companies with global ambitions, particularly in the fields of artificial intelligence (AI) and healthcare. N1 manages $60 million across two funds, indicating a strong commitment to nurturing innovative startups.
The firm has established itself as a key player in the venture capital landscape, particularly in North America and Europe. N1's investment strategy emphasizes operational support and strategic guidance, leveraging the extensive experience of its team to help entrepreneurs navigate the complexities of scaling their businesses across borders. The firm has invested in over 60 companies, showcasing its active engagement in the startup ecosystem.
Notable milestones include the successful backing of companies like Myriad AI and NovoFlow, which highlight N1's focus on AI-driven solutions in healthcare and regulatory compliance. The firm’s dual presence in major tech hubs allows it to tap into diverse markets and foster cross-border collaborations.
N1 invests primarily in early-stage companies within the sectors of artificial intelligence (AI), healthtech, and frontier technology. The firm operates across North America and Europe, managing a total of $60 million across two funds. N1 typically makes initial investments ranging from $100,000 to $1 million, targeting startups that demonstrate innovative potential and are poised for significant growth.
The firm seeks founders who possess global ambitions and are looking to scale their businesses internationally. N1's investment strategy is characterized by a hands-on approach, providing not only capital but also operational support and strategic guidance. This support is crucial for early-stage companies navigating the challenges of market entry and expansion.
In addition to AI and healthcare, N1 has shown interest in frontier technologies, indicating a willingness to explore adjacent sectors that align with its investment thesis. The firm values innovative solutions that can disrupt traditional industries and create lasting impact.
N1 has built a diverse portfolio of over 60 companies, showcasing its commitment to early-stage investments in high-potential sectors. Notable portfolio companies include:
This portfolio reflects N1's strategic focus on AI and healthcare, with companies that are positioned to leverage technology for improved outcomes in their respective fields. The firm’s investments demonstrate a commitment to supporting innovative solutions that address real-world challenges.
Marek Moravec - Partner / Managing Partner. Marek is a founder of N1 and has a background in building startups, including Lazada.com. He is an Oxford graduate and brings significant operational expertise to the firm.
Jaroslav Trojan - Partner / Managing Partner. Jaroslav is a key figure at N1, contributing to the firm's strategic direction and investment decisions. His experience in venture capital enhances N1's capabilities in supporting early-stage companies.
Klára Kocárová - Partner. Klára plays a vital role in N1's investment strategy, focusing on identifying promising startups and supporting their growth. Her insights into the startup ecosystem are invaluable to the firm.
Ondřej Homola - Partner. Ondřej co-founded StartMonday and leads N1's expansion efforts in Ukraine. His experience in the region allows N1 to tap into emerging markets and support founders with global ambitions.
To pitch N1, founders should send an email to futureunicorns@n1.rocks. It is important to include a concise overview of the startup, the problem it addresses, and the team behind it. N1 values clear communication and straightforward presentations.
While there is no specific pitch form or URL disclosed, founders should aim to provide a compelling narrative that outlines their vision and potential for growth. N1 emphasizes fast decision-making, so founders can expect a timely response once their pitch is submitted.
Warm introductions are not explicitly required, but they can enhance the chances of getting noticed. Founders are encouraged to leverage their networks to connect with N1's team if possible.
In September 2025, N1 participated in a $7.8 million seed round for **Myriad AI**, an AI-powered regulatory compliance platform. This investment underscores N1's commitment to supporting innovative solutions in heavily regulated industries.
In January 2024, N1 was involved in a funding round for **Hedepy**, an online psychology and psychiatry platform, contributing EUR 3.85 million. This investment highlights N1's focus on healthtech and its dedication to addressing mental health challenges through technology.
What are N1's investment criteria?
N1 focuses on early-stage companies in the AI, healthtech, and frontier technology sectors. They typically invest between $100,000 and $1 million in startups that demonstrate innovative potential and global ambitions.
How can I pitch to N1?
Founders can reach out to N1 via email at futureunicorns@n1.rocks. It is advisable to include a clear overview of the business, the problem it addresses, and the team behind it.
What makes N1 different from other investors?
N1 provides not only capital but also operational support and strategic guidance. The investment team has startup-building experience, which allows them to assist founders in navigating challenges and accelerating growth.
What is N1's geographic focus?
N1 operates primarily in North America and Europe, with a particular interest in supporting founders who aim to scale their businesses internationally.
What is the typical decision timeline for investments?
While specific timelines are not disclosed, N1 emphasizes fast decision-making and straightforward communication with founders throughout the investment process.
Does N1 provide follow-on investments?
N1 has a history of supporting its portfolio companies through follow-on investments, ensuring that they have the necessary resources to continue their growth trajectory.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.